CYP19A1 and breast cancer: Twelve months after CPA, the patient underwent left mastectomy and axillary lymph node dissection (II) for left breast cancer. Postoperatively, the patient continued to receive aromatase inhibitors and radiation therapy and she did not experience any recurrence two years after surgery.